Skip to content
latin-america-header

LATIN AMERICA

Latin America includes a portfolio of locally recognised and trusted brands sold across the public and private sector. Brazil and Mexico are the biggest contributors to regional performance.

Key Countries

Brazil
Chile
Colombia
Ecuador
Mexico

latin-america
  • The Brazilian private pharmaceutical market declined 3%, negatively impacted by foreign exchange movements and was valued by IQVIA at USD26 billion, while the Brazilian pharmaceutical market in local currency grew 11% for the year 30 June 2020.

Source: IQVIA – June 2020

STATISTICS

Number of products launched:

6

(2019: 8)

Average staff turnover*:

27%

(2019: 25%)

Number of product recalls:

Nil

(2019: Nil)

Number of work-related fatalities:

Nil

(2019: Nil)

* Rate excludes employees transferred in Nutritionals disposal.

Number of permanent employees

736

June 2020

773

June 2019

Revenue 2020
R’million
2019 (CER)
R’million
Change
%
Regional Brands 2 342 2 136 10
Sterile Focus Brands 1 070 957 12
Anaesthetics Brands 994 882 13
Thrombosis Brands 76 75 1
Total 3 412 3 093 10

Note: Commercial Pharmaceuticals revenue is disclosed by customer geography.

Scroll To Top